Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 110.50
-2.00 (-1.78%)
Jul 29, 2026, 1:30 PM CST
Bioteque Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,163 | 2,135 | 2,073 | 1,945 | 2,010 | 1,825 |
Revenue Growth | 3.27% | 3.03% | 6.58% | -3.26% | 10.12% | -6.27% |
Gross Profit Gross Profit Growth | 959.27 | 936.94 | 905.08 | 818.94 | 844.54 | 802.87 |
Operating Income Operating Income Growth | 687.17 | 670.28 | 643.17 | 580.18 | 578.38 | 547.93 |
Net Income Net Income Growth | 549.63 | 539.19 | 528.26 | 452.55 | 493.54 | 431.26 |
Earnings Per Share EPS Growth | 7.89 | 7.74 | 7.59 | 6.50 | 7.09 | 6.20 |
EPS Growth | 2.33% | 1.98% | 16.77% | -8.32% | 14.36% | -11.68% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Adjustments and Eliminations Adjustments and Eliminations Growth | -26.62 | -26.57 | -26.06 | -26.5 | -26.8 | -22.69 |
Manufacture and Sale of Soft Bags for Medical Catheters and Medicines for Use by Medical Institutions Manufacture and Sale of Soft Bags for Medical Catheters and Medicines for Use by Medical Institutions Growth | 483.78 | 466.94 | 391.17 | 416.76 | 397.45 | 264.21 |
Other Department Other Department Growth | 86.73 | 87.88 | 45.46 | 39.26 | 12.88 | 11 |
Manufactures Dialysis-Related Products and Sells Them to Distributors and Retailers around The World Manufactures Dialysis-Related Products and Sells Them to Distributors and Retailers around The World Growth | 612.43 | 609.53 | 669.75 | 626.04 | 756.68 | 704.37 |
Manufacture and Sale of Medical-Grade Key Components and Internal Catheters for Use by Various Medical Institutions Manufacture and Sale of Medical-Grade Key Components and Internal Catheters for Use by Various Medical Institutions Growth | 1,022 | 1,013 | 1,006 | 900.12 | 872.19 | 868.61 |
Total Total Growth | 2,179 | 2,151 | 2,086 | 1,956 | 2,012 | 1,825 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,797 | 1,667 | 1,596 | 1,565 | 1,267 | 1,284 |
Total Debt Total Debt Growth | 531.96 | 597.38 | 740.63 | 894.53 | 872.43 | 471.55 |
Net Cash (Debt) Net Cash Growth | 1,265 | 1,070 | 855.82 | 670.01 | 394.53 | 812.29 |
Net Cash Growth | 20.26% | 24.97% | 27.73% | 69.82% | -51.43% | -27.54% |
Net Cash Per Share Net Cash Per Share Growth | 18.14 | 15.35 | 12.29 | 9.62 | 5.66 | 11.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 702.85 | 664.2 | 702.62 | 679.38 | 644.58 | 469.25 |
Capital Expenditures CapEx Growth | -95.35 | -57.2 | -98.13 | -72.76 | -726.83 | -550.87 |
Free Cash Flow Free Cash Flow Growth | 607.49 | 607 | 604.49 | 606.62 | -82.25 | -81.63 |
Free Cash Flow Growth | -4.91% | 0.41% | -0.35% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.34% | 43.88% | 43.67% | 42.11% | 42.01% | 43.98% |
Operating Margin | 31.77% | 31.39% | 31.03% | 29.83% | 28.77% | 30.01% |
Pretax Margin | 31.80% | 31.59% | 32.73% | 29.29% | 31.00% | 29.48% |
Profit Margin | 25.41% | 25.25% | 25.49% | 23.27% | 24.55% | 23.62% |
FCF Margin | 28.08% | 28.43% | 29.17% | 31.19% | -4.09% | -4.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 5.500 | 5.500 | 5.000 | 4.500 | 4.500 | 4.500 |
Dividend Per Share Growth | 10.00% | 10.00% | 11.11% | 0% | 0% | 12.50% |
Dividend Yield | 4.89% | 4.56% | 4.23% | 4.42% | 4.55% | 4.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.01 | 15.49 | 16.20 | 16.84 | 15.66 | 18.40 |
Forward PE | - | 15.11 | 16.04 | 20.51 | 14.65 | 15.05 |
P/FCF Ratio | 12.61 | 13.76 | 14.16 | 12.57 | - | - |
PS Ratio | 3.54 | 3.91 | 4.13 | 3.92 | 3.84 | 4.35 |